Persistence of antibodies induced by measles-mumps-rubella vaccine in children in India

Clinical and Vaccine Immunology

Volumn 14, Issue 10, 2007, Pages 1370-1371

  Raut, S K ^a   Kulkarni, P S ^a   Phadke, M A ^b   Jadhav, S S ^a   Kapre, S V ^a   Dhere, R M ^a   Dhorje, S P ^a   Godse, S R ^a  

^a Serum Institute of India Ltd   (India)

^b MAHARASHTRA UNIVERSITY OF HEALTH SCIENCES   (India)

Author keywords

[No Author keywords available]

Indexed keywords

MEASLES MUMPS RUBELLA VACCINE;

ANTIBODY RESPONSE; ARTICLE; CLINICAL ASSESSMENT; DRUG EFFICACY; DRUG MECHANISM; FOLLOW UP; HUMAN; IMMUNE RESPONSE; IMMUNITY; PRIORITY JOURNAL; RISK ASSESSMENT; SINGLE DRUG DOSE; VACCINATION;

ADOLESCENT; ANTIBODIES, VIRAL; CHILD; CHILD, PRESCHOOL; FEMALE; HUMANS; IMMUNIZATION SCHEDULE; INDIA; INFANT; MALE; MEASLES-MUMPS-RUBELLA VACCINE; TIME FACTORS;

EID: 35548962335     PISSN: 15566811     EISSN: None     Source Type: Journal    
DOI: 10.1128/CVI.00246-07     Document Type: Article

References (13)

1. Anonymous. 2007. Mumps virus vaccines. Wkly. Epidemiol. Rec. 82:51-60.
2. Bhargava, I., B. C. Chhaparwal, M. A. Phadke, S. F. Irani, D. Chhaparwal, S. Dhorje, and C. P. Maheshwari. 1995. Immunogenicity and reactogenicity of indigenously produced MMR vaccine. Indian Pediatr. 32:983-988.
3. Boulianne, N., G. De Serres, S. Ratnam, B. J. Ward, J. R. Joly, and B. Duval. 1995. Measles, mumps, and rubella antibodies in children 5-6 years after immunization: effect of vaccine type and age at vaccination. Vaccine 13: 1611-1616.
4. Briss, P. A., L. J. Fehrs, R. A. Parker, P. F. Wright, E. C. Sannella, R. H. Hutcheson, and W. Schaffner. 1994. Sustained transmission of mumps in a highly vaccinated population: assessment of primary vaccine failure and waning vaccine-induced immunity. J. Infect. Dis. 169:77-82.
5. Centers for Disease Control and Prevention. 2006. Update: multistate outbreak of mumps, United States, January 1-May 2, 2006. Morb. Mortal. Wkly. Rep. 55:559-563.
6. Markowitz, L. E., S. R. Preblud, P. E. Fine, and W. A. Orenstein. 1990. Duration of live measles vaccine-induced immunity. Pediatr. Infect. Dis. J. 9:101-110.
7. Paunio, M., H. Peltola, M. Valle, I. Davidkin, M. Virtanen, and O. P. Heinonen. 1998. Explosive school-based measles outbreak: intense exposure may have resulted in high risk, even among revaccinees. Am. J. Epidemiol. 148:1103-1110.
8. Singhal, T., Y. K. Amdekar, N. Thacker, and the Indian Academy of Pediatrics. 2007. IAP Committee on Immunization. Indian Pediatr. 44:390-392.
9. Usonis, V., V. Bakasenas, and M. Denis. 2001. Neutralization activity and persistence of antibodies induced in response to vaccination with a novel mumps strain, RIT 4385. Infection 29:159-162.
10. Vandermeulen, C., M. Roelants, M. Vermoere, K. Roseeuw, P. Goubau, and K. Hoppenbrouwers. 2004. Outbreak of mumps in a vaccinated child population: a question of vaccine failure? Vaccine 22:2713-2716.
11. Watson, J. C., S. C. Hadler, C. A. Dykewicz, S. Reef, and L. Phillips. 1998. Measles, mumps, and rubella: vaccine use and strategies for elimination of measles, rubella, and congenital rubella syndrome and control of mumps. Recommendations of the Advisory Committee on Immunization Practices (ACIP). Morb. Mortal. Wkly. Rep. Recommend. Rep. 47:1-57.
12. Yadav, S., R. Thukral, and A. Chakarvarti. 2003. Comparative evaluation of measles, mumps and rubella vaccine at 9 and 15 months of age. Indian J. Med. Res. 118:183-186.
13. Yeung, L. F., P. Lurie, G. Dayan, E. Eduardo, P. H. Britz, S. B. Redd, M. J. Papania, and J. F. Seward. 2005. A limited measles outbreak in a highly vaccinated US boarding school. Pediatrics 116:1287-1291.